financetom
Business
financetom
/
Business
/
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
Jul 3, 2025 8:06 AM

(Reuters) -Summit Therapeutics ( SMMT ) and AstraZeneca ( AZN ) are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with the matter.

Under the potential deal, AstraZeneca ( AZN ) could license Summit's experimental lung-cancer treatment, ivonescimab, the report said.

Summit did not immediately respond to Reuters request seeking comment, while an AstraZeneca ( AZN ) spokesperson declined to comment.

A deal between the companies could include an upfront payment of several billion dollars to Summit and milestone payments later on, Bloomberg News said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved